Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

PDO threads may help regrow hair and increase thickness in hair loss.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

Dystonia may be part of PAS-4 and linked to immune issues.

Psoriasis patients are more likely to experience maladaptive daydreaming.

Shorter PSADT after prostate surgery is linked to higher risk of death.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Most patients with anal Pemphigus Vulgaris had repeated episodes but fully recovered with treatment, without long-term problems.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Adding Platelet-Rich Plasma to hair implantation improves hair growth and graft survival.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

p63 and p73 regulate the vitamin D receptor, affecting cancer cell behavior and vitamin D sensitivity.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

More research is needed on the safety of fathers' drug exposure before conception.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.